Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030

Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030

The global Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 51.02 million in 2024 to US$ 70.25 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period.

At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key players include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech and so on. JSR Life Sciences is the largest player, accounting for 47.55% revenue share globally in 2023.

In terms of product types, the mainstream product on the market is carboxy-modified latex particles, which occupies more than 60% of the market share. As for product applications, latex immunoturbidimetry is the largest application direction, accounting for more than 50%.

For consumption, North America, China and Europe are the main consumption areas, cumulatively accounting for 93.27% of the global total sales in 2023.

In terms of production side, this report researches the Latex Particle for In-Vitro Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Latex Particle for In-Vitro Diagnostics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Includes:

This report presents an overview of global market for Latex Particle for In-Vitro Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Latex Particle for In-Vitro Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Latex Particle for In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latex Particle for In-Vitro Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Latex Particle for In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Latex Particle for In-Vitro Diagnostics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, and VDO Biotech, etc.

Market Segmentation

By Company

JSR Life Sciences

Merck

Bangs Laboratories

Thermo Fisher

Agilent

IKERLAT Polymers

Fujikura Kasei

CD Bioparticles

VDO Biotech

Suzhou NanoMicro

Sunresin New Materials

Segment by Type

Plain Latex Particles

Carboxy-Modified Latex Particles

Other

Segment by Application

Latex Immunoturbidimetry

Latex Agglutination Test

Immunochromatography

Other

Production by Region

North America

Europe

China

Japan

Sales by Region

US & Canada

U.S.

Canada

China

Asia (excluding China)

Japan

South Korea

China Taiwan

Southeast Asia

IndiaEurope

Germany

France

U.K.

Italy

Russia

Middle East, Africa, Latin America

Brazil

Mexico

Turkey

GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Latex Particle for In-Vitro Diagnostics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Latex Particle for In-Vitro Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latex Particle for In-Vitro Diagnostics sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.